3/8/2019
• Posted by Provider Relations
Fidelis Care has made changes to our Medicaid Managed Care/Child Health Plus/HealthierLife; Metal Level; and Essential Plan Formularies.
2/27/2019
• Posted by Provider Relations
The following sections of the Fidelis Care authorization grids have been updated effective April 1, 2019.
1/31/2019
• Posted by Provider Relations
The following section of the Fidelis Care authorization grids has been updated effective March 1, 2019.
1/31/2019
• Posted by Provider Relations
Fidelis Care is pleased to inform you that the most recent 2019 QARR Non-Compliance Report has been posted on Provider Access Online (provider portal). This information is indicative of all encounter data on file with Fidelis Care as of 12/10/2018.
1/28/2019
• Posted by Provider Relations
As many biosimilars come to market in the next several years, their use in oncology will play an important role in the future care of patients with cancer. The American Society of Clinical Oncology (ASCO) is committed to providing education and guidance to the oncology community on the use of biosimilars in the cancer setting.
Newer Articles
Older Articles